Dexcom welcomed the advocates to a photoshoot in Los Angeles that included Grammy-nominated artist, actor, producer and ...

Dexcom’s World Diabetes Day campaign provides a platform for the selected individuals to advocate for diabetes awareness ...

Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

DexCom beat expectations in the third quarter, and it raised its revenue guidance for the full year. Manufacturing issues are putting pressure on margins. For 2026, the company sees growth missing ...

DexCom was hit with a consumer class action on Oct. 22 in California Southern District Court over allegations it made unauthorized design changes to its G6 and G7 continuous glucose monitors without ...

Bullish option flow detected in DexCom (DXCM) with 4,618 calls trading, 1.3x expected, and implied vol increasing almost 3 points to 63.76%. Dec-25 85 calls and 10/24 weekly 73 calls are the most ...

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. Piper Sandler highlighted that DexCom stock is currently trading at its lowest valuation level in ...

DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade ...

If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last ...

Numerous comments on a Facebook group called “Dexcom G7 – Issues and Complaints” has brought to light a problem that users are referring to as “goose necking.” MD+DI learned more about this issue – ...